Gadolinium-enhanced magnetic resonance angiography in neonates and infants suspected of caval or aortic thrombosis

Background: Gadolimum-enhanced magnetic resonance angiography (MRA) is a well-established technique in older children and adults. No studies have focused on its use in neonates and small infants. Objective: Our objective was to study the use of gadolinium-enhanced MRA in neonates and infants suspected of caval or aortic thrombosis. Materials and Methods: Gadolinium-enhanced MR angiography was performed on seven neonates and small infants for the evaluation of caval or aortic thrombosis. Gadolinium-DTPA at a dose of 0.3 mmol/kg (minimum dose 1 ml) was injected using a power injector (0.2 ml/s). Contrast-enhanced MRA was performed using a 3-D, fast, radiofrequency spoiled gradient-echo sequence (TR/TE: 4.8/1.1, flip angle 45degrees, matrix 256x128, slice thickness 2.6 mm interpolated to 1.3 mm, FOV variable, NEX = 1.0). Results: Diagnostic-quality angiograms were obtained in all seven neonates. Superior vena cava thrombosis was identified in two neonates, and abdominal aortic thrombosis was present in one neonate. Conclusion: It is practical to perform gadolinium-enhanced MRA in neonates weighing as little as 600 g for the detection of caval or aortic thrombosis.